Prevention of gastric cancer with antibiotics: can it be done without eradicating Helicobacter pylori?

J Natl Cancer Inst. 2014 Jun 12;106(7):dju148. doi: 10.1093/jnci/dju148. Print 2014 Jul.

Authors

Daniel E Freedberg¹, Julian A Abrams², Timothy C Wang²

Affiliations

¹ Affiliation of authors: Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY (DEF, JAA, TCW). def2004@cumc.columbia.edu.
² Affiliation of authors: Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY (DEF, JAA, TCW).

PMID: 24925352
DOI: 10.1093/jnci/dju148

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Female
Helicobacter Infections / drug therapy*
Helicobacter pylori / drug effects*
Humans
Male
Precancerous Conditions / drug therapy*
Stomach Neoplasms / epidemiology*
Stomach Neoplasms / prevention & control*

Substances

Anti-Bacterial Agents

Grants and funding